Franklin Resources Inc. Purchases Shares of 83,649 DENTSPLY SIRONA Inc. $XRAY

Franklin Resources Inc. acquired a new stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) in the second quarter, according to the company in its most recent filing with the SEC. The firm acquired 83,649 shares of the medical instruments supplier’s stock, valued at approximately $1,328,000.

A number of other hedge funds have also recently modified their holdings of XRAY. Bank of Nova Scotia raised its position in DENTSPLY SIRONA by 347.5% during the first quarter. Bank of Nova Scotia now owns 84,254 shares of the medical instruments supplier’s stock valued at $1,259,000 after acquiring an additional 65,426 shares in the last quarter. Vanguard Group Inc. grew its stake in shares of DENTSPLY SIRONA by 2.8% during the 1st quarter. Vanguard Group Inc. now owns 20,740,589 shares of the medical instruments supplier’s stock worth $309,864,000 after purchasing an additional 557,329 shares during the period. Charles Schwab Investment Management Inc. increased its holdings in shares of DENTSPLY SIRONA by 0.3% during the 1st quarter. Charles Schwab Investment Management Inc. now owns 2,108,014 shares of the medical instruments supplier’s stock valued at $31,494,000 after purchasing an additional 6,881 shares in the last quarter. Headlands Technologies LLC lifted its stake in shares of DENTSPLY SIRONA by 1,657.9% in the 1st quarter. Headlands Technologies LLC now owns 98,109 shares of the medical instruments supplier’s stock valued at $1,466,000 after purchasing an additional 92,528 shares during the period. Finally, Deutsche Bank AG boosted its holdings in DENTSPLY SIRONA by 292.1% during the first quarter. Deutsche Bank AG now owns 61,645 shares of the medical instruments supplier’s stock worth $921,000 after buying an additional 45,925 shares in the last quarter. Hedge funds and other institutional investors own 95.70% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have weighed in on XRAY shares. Evercore ISI cut their price objective on shares of DENTSPLY SIRONA from $17.00 to $13.00 and set an “in-line” rating for the company in a report on Wednesday, October 8th. UBS Group cut their price target on DENTSPLY SIRONA from $24.00 to $23.00 and set a “buy” rating for the company in a research note on Tuesday, October 28th. Mizuho set a $13.00 price target on DENTSPLY SIRONA in a research report on Friday, November 7th. Needham & Company LLC restated a “hold” rating on shares of DENTSPLY SIRONA in a research report on Friday, September 26th. Finally, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of DENTSPLY SIRONA in a research note on Wednesday, October 8th. Two equities research analysts have rated the stock with a Buy rating, ten have given a Hold rating and two have given a Sell rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $16.08.

DENTSPLY SIRONA Price Performance

Shares of DENTSPLY SIRONA stock opened at $11.25 on Friday. The stock has a market capitalization of $2.24 billion, a P/E ratio of -2.55, a PEG ratio of 0.82 and a beta of 1.01. The business has a 50 day simple moving average of $11.90 and a two-hundred day simple moving average of $13.93. DENTSPLY SIRONA Inc. has a 12 month low of $9.85 and a 12 month high of $20.59. The company has a debt-to-equity ratio of 1.36, a current ratio of 1.47 and a quick ratio of 0.99.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings results on Thursday, November 6th. The medical instruments supplier reported $0.37 EPS for the quarter, missing the consensus estimate of $0.45 by ($0.08). The firm had revenue of $904.00 million for the quarter, compared to analysts’ expectations of $900.33 million. DENTSPLY SIRONA had a positive return on equity of 17.10% and a negative net margin of 24.34%.The firm’s revenue for the quarter was down 4.9% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.50 earnings per share. DENTSPLY SIRONA has set its FY 2025 guidance at 1.600-1.600 EPS. As a group, analysts predict that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current fiscal year.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.